Compare Globus Medical Inc. Class A Common Stock (GMED) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Cloudflare Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Cloudflare Inc trades at $318.2 (market cap $123.81B). The key difference: Cloudflare Inc is far larger — about 12.1× Globus Medical Inc. Class A Common Stock's market cap, and Cloudflare Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Cloudflare Inc for 61 Days on average.
| GMED | NET | |
|---|---|---|
Market Cap | $10.25B | $123.81B |
Volume | 1,108,124 | 1,745,042 |
Sector | Health | Technology |
52-Week High | $96.82 | $361.00 |
52-Week Low | $58.33 | $160.16 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $9.76B | $123.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Cloudflare (NET) trades at $324.01, down 7.6% over 24 hours, amid a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, with key support at $328. Fundamentally, revenue growth is strong, reaching $2.17B in 2025, but profitability remains a challenge with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and a partnership with Deutsche Telekom, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst consensus and strategic initiatives, but high valuation multiples and persistent losses pose risks. Investment opportunity lies in continued top-line expansion and market share gains, while key risks include competitive pressures and execution on path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
